National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer

Clinical Trial Results

Summaries of Newsworthy Clinical Trial Results

< Back to Main

Related Pages
Coping with Cancer 1
Managing side effects and complications caused by cancer and its treatment.

Search for Clinical Trials 2
NCI's PDQ® Cancer Clinical Trials Registry.
Supportive Care Trial Results
1.  Depression Management Effective in Low-Income Hispanic Cancer Patients 3
(Posted: 11/20/2008) - A collaborative-care intervention to treat depression in cancer patients was more effective than usual care in relieving symptoms of depression among low-income Hispanics, according to the Sept. 20, 2008, Journal of Clinical Oncology.

2.  IV Iron Effective in Treating Chemotherapy-Induced Anemia 4
(Posted: 04/21/2008) - Two studies in the April 1, 2008, Journal of Clinical Oncology found that intravenous iron significantly improves hemoglobin levels in patients taking erythropoietin-stimulating agents (ESAs) for chemotherapy-induced anemia compared with ESAs alone or ESAs plus oral iron.

3.  Hypnosis Before Breast-Cancer Surgery Reduces Pain, Discomfort, and Cost 5
(Posted: 09/12/2007) - Women undergoing surgery for breast cancer who received hypnosis before entering the operating room required less anesthesia and pain medication during surgery, and reported less pain, nausea, fatigue, and discomfort after surgery than women who did not receive hypnosis, according to the Sept. 5, 2007, Journal of the National Cancer Institute.

4.  Granulocyte Colony-Stimulating Factor (G-CSF) Prevents Common Chemotherapy Complication 6
(Posted: 08/15/2007) - A combined analysis confirmed that cancer patients receiving chemotherapy are less likely to suffer febrile neutropenia when they also receive drugs that stimulate white blood cell production, according to the July 20, 2007, Journal of Clinical Oncology.

5.  Gabapentin Helps Hot Flashes From Prostate Cancer Treatment 7
(Posted: 06/20/2007) - The drug gabapentin (Neurontin®) effectively reduced the intensity and duration of hot flashes in a clinical trial of more than 200 men receiving hormonal treatment for their prostate cancer, according to findings presented at the 2007 ASCO meeting in Chicago.
1 2 8 3 9 4 10   Next > 8


Table of Links

1http://www.cancer.gov/cancertopics/coping
2http://www.cancer.gov/clinicaltrials/search
3http://www.cancer.gov/clinicaltrials/results/depression1108
4http://www.cancer.gov/clinicaltrials/results/ESA0408
5http://www.cancer.gov/clinicaltrials/results/hypnosis0907
6http://www.cancer.gov/clinicaltrials/results/neutropenia0807
7http://www.cancer.gov/clinicaltrials/results/gabapentin-men0607
8http://www.cancer.gov/clinicaltrials/results/supportive-care?keyword=supportive
&page=2
9http://www.cancer.gov/clinicaltrials/results/supportive-care?keyword=supportive
&page=3
10http://www.cancer.gov/clinicaltrials/results/supportive-care?keyword=supportive
&page=4